| 000 | 01512 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250512201556.0 | ||
| 264 | 0 | _c19821221 | |
| 008 | 198212s 0 0 eng d | ||
| 022 | _a0049-3848 | ||
| 024 | 7 |
_a10.1016/0049-3848(82)90082-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeuleman, D G | |
| 245 | 0 | 0 |
_aA novel anti-thrombotic heparinoid (Org 10172) devoid of bleeding inducing capacity: a survey of its pharmacological properties in experimental animal models. _h[electronic resource] |
| 260 |
_bThrombosis research _cAug 1982 |
||
| 300 |
_a353-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
| 650 | 0 | 4 | _aBlood Platelets |
| 650 | 0 | 4 | _aChondroitin Sulfates |
| 650 | 0 | 4 | _aDermatan Sulfate |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xadverse effects |
| 650 | 0 | 4 |
_aGlycosaminoglycans _xpharmacology |
| 650 | 0 | 4 |
_aHeparin _xpharmacology |
| 650 | 0 | 4 |
_aHeparinoids _xadverse effects |
| 650 | 0 | 4 | _aHeparitin Sulfate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred Strains |
| 650 | 0 | 4 |
_aThrombophlebitis _xdrug therapy |
| 700 | 1 | _aHobbelen, P M | |
| 700 | 1 | _avan Dedem, G | |
| 700 | 1 | _aMoelker, H C | |
| 773 | 0 |
_tThrombosis research _gvol. 27 _gno. 3 _gp. 353-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0049-3848(82)90082-2 _zAvailable from publisher's website |
| 999 |
_c6182672 _d6182672 |
||